185490 — EyeGene Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for EyeGene, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-34,569	-26,489	-22,430	-12,896	-19,077
Depreciation
Amortisation
Non-Cash Items	2,089	7,244	-1,387	-498	10,165
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,406	-613	1,615	-1,121	854
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-30,004	-18,568	-20,065	-12,171	-5,981
Capital Expenditures	-2,827	-906	-1,666	-4,987	-1,223
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-53,849	18,155	7,338	12,325	-4,133
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-56,677	17,249	5,672	7,338	-5,356
Financing Cash Flow Items	-289	772	491	151	107
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	86,624	880	17,853	647	20,068
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-74	-603	3,450	-4,071	8,769